Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

HIV Infection

Free Subscription 24.04.2023 14 AIDS 2 AIDS Res Hum Retroviruses 2 Am J Epidemiol 2 Antimicrob Agents Chemother 6 Clin Infect Dis 2 HIV Med 4 J Acquir Immune Defic Syndr 1 J Clin Invest 4 J Infect Dis 1 JAMA 1 Lancet 1 Nat Rev Immunol 1 Neurol Clin Pract 2 Pediatrics 5 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. WOMACK JA, Murphy TE, Leo-Summers L, Kidwai-Khan F, et al
   Performance of a modified fracture risk assessment tool (FRAX) for fragility fracture prediction among older veterans living with HIV.
   AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003566.
   PubMed         Abstract available
   
   
2. CHONGXING Z, Yuanchun L, Yan H, Dabin L, et al
   Evaluation of the Diagnostic Efficacy of EC-Test for Latent Tuberculosis Infection in Ambulatory People Living with HIV.
   AIDS. 2023 Apr 20. doi: 10.1097/QAD.0000000000003573.
   PubMed         Abstract available
   
   
3. MARTYN-DICKENS C, Ojewale O, Sly-Moore E, Dompreh A, et al
   Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg.
   AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003576.
   PubMed         Abstract available
   
   
4. SADA YH, da Costa WL Jr, Kramer JR, Chiao EY, et al
   Survival outcomes in Veterans with hepatocellular carcinoma, with and without HIV infection.
   AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003568.
   PubMed         Abstract available
   
   
5. ZHANG Z, Duri K, Duisters KLW, Schoeman JC, et al
   Altered methionine-sulfone levels are associated with impaired growth in HEU-children.
   AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003574.
   PubMed         Abstract available
   
   
6. REDDON H, Fairbairn N, Grant C, Milloy MJ, et al
   Experiencing homelessness and progression through the HIV cascade of care among people who use drugs.
   AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003570.
   PubMed         Abstract available
   
   
7. RUBIN LH, Du Y, Sweeney SE, O'Toole R, et al
   Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
   AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003572.
   PubMed         Abstract available
   
   
8. MARAGH-BASS AC, Stoner M, Castellanos-Usigli A, Agarwal H, et al
   New PrEP options need different counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities (YSGM) of color.
   AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003563.
   PubMed        
   
   
9. LI MJ, Chau B, Garland WH, Oksuzyan S, et al
   Racial, gender, and psychosocial disparities in viral suppression trends among people receiving coordinated HIV care in Los Angeles County.
   AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003578.
   PubMed         Abstract available
   
   
10. RIVERA AS, Rusie LK, Feinstein MJ, Siddique J, et al
    Intersectionality-informed analysis of durable viral suppression disparities in people with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003565.
    PubMed         Abstract available
    
    
11. TEBAS P, Lynn K, Azzoni L, Cocchella G, et al
    Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons.
    AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003575.
    PubMed         Abstract available
    
    
12. REQUENA MB, Grabar S, Lanoy E, Pialoux G, et al
    Mortality in HCV-cured versus HCV-uninfected people with HIV: a matched analysis in the ANRS CO4 FHDH cohort.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003569.
    PubMed         Abstract available
    
    
13. GRIFFIN DW, Pai Mangalore R, Hoy JF, Mcmahon JH, et al
    Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003579.
    PubMed         Abstract available
    
    
14. FREDERIX K, Schwitters A, Chung G, Mccracken S, et al
    The state of the pediatric HIV epidemic in Lesotho: results from a population-based survey.
    AIDS. 2023 Apr 19. doi: 10.1097/QAD.0000000000003581.
    PubMed         Abstract available
    
    

    
    AIDS Res Hum Retroviruses

15. PEREZ BARRAGAN E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al
    Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2022.0130.
    PubMed         Abstract available
    
    
16. PILKINGTON V, Quinn K, Campbell LJ, Payne L, et al
    CLINICAL PRESENTATION OF MPOX IN PEOPLE WITH AND WITHOUT HIV IN THE UNITED KINGDOM DURING THE 2022 GLOBAL OUTBREAK.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2023.0014.
    PubMed         Abstract available
    
    

    
    Am J Epidemiol

17. SEWAK A, Lodi S, Li X, Shu D, et al
    Causal effects of stochastic PrEP interventions on HIV incidence among men who have sex with men.
    Am J Epidemiol. 2023 Apr 19:kwad097. doi: 10.1093.
    PubMed         Abstract available
    
    
18. SACK DE, Shepherd BE, Audet CM, De Schacht C, et al
    Inverse Probability Weights for Quasi-Continuous Ordinal Exposures with a Binary Outcome: Method Comparison and Case Study.
    Am J Epidemiol. 2023 Apr 14:kwad085. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

19. XIAO MA, Cleyle J, Yoo S, Forrest M, et al
    The G118R plus R263K Combination of Integrase Mutations Associated with Dolutegravir-Based Treatment Failure Reduces HIV-1 Replicative Capacity and Integration.
    Antimicrob Agents Chemother. 2023 Apr 18:e0138622. doi: 10.1128/aac.01386.
    PubMed         Abstract available
    
    
20. HONG H, Aslam-Mir U, Kajubi R, Wallender E, et al
    Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.
    Antimicrob Agents Chemother. 2023 Mar 14:e0142722. doi: 10.1128/aac.01427.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

21. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.
    PubMed        
    
    
22. HAZRA A, Cherabie JN
    Is Mpox a Sexually Transmitted Infection? Why Narrowing the Scope of This Disease May Be Harmful.
    Clin Infect Dis. 2023;76:1504-1507.
    PubMed         Abstract available
    
    
23. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    PubMed         Abstract available
    
    
24. LEVISON J, McKinney J, Duque A, Hawkins J, et al
    Breastfeeding among people with HIV in North America: a multisite study.
    Clin Infect Dis. 2023 Apr 20:ciad235. doi: 10.1093.
    PubMed         Abstract available
    
    
25. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    PubMed         Abstract available
    
    
26. VERDECIA JL, Vootukuri SR, Sands ML, Isache CL, et al
    A Case of Necrotizing Finger Lesions in a Patient With AIDS.
    Clin Infect Dis. 2023;76:1513-1515.
    PubMed        
    
    

    
    HIV Med

27. COUKAN F, Murray KK, Papageorgiou V, Lound A, et al
    Barriers and facilitators to HIV Pre-Exposure Prophylaxis (PrEP) in Specialist Sexual Health Services in the United Kingdom: A systematic review using the PrEP Care Continuum.
    HIV Med. 2023 Apr 19. doi: 10.1111/hiv.13492.
    PubMed         Abstract available
    
    
28. GILLES C, Konopnicki D, Rozenberg S
    The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
    HIV Med. 2023 Apr 16. doi: 10.1111/hiv.13490.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

29. OMOLLO V, Asewe M, Mogere P, Maina G, et al
    The fidelity of a pharmacy-based oral HIV pre-exposure prophylaxis delivery model in Kenya.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003208.
    PubMed         Abstract available
    
    
30. GANDHI AR, Hyle EP, Scott JA, Lee JS, et al
    The clinical impact and cost-effectiveness of clinic-based cognitive behavioral therapy for people with HIV, depression, and virologic failure in South Africa.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003205.
    PubMed         Abstract available
    
    
31. LEW C, Fairley CK, Tran J, Phillips TR, et al
    High risk sexual activities and condom use patterns during group sex among men who have sex with men in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003211.
    PubMed         Abstract available
    
    
32. LESIAPETO M, Shults J, Mmunyane M, Matshaba M, et al
    Stunted Growth is Associated with Dyslipidemia in Young Adults with Perinatal HIV Infection.
    J Acquir Immune Defic Syndr. 2023 Apr 17. doi: 10.1097/QAI.0000000000003209.
    PubMed         Abstract available
    
    

    
    J Clin Invest

33. PIERCE CA, Loh LN, Steach HR, Cheshenko N, et al
    HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal.
    J Clin Invest. 2023 Apr 20:e164317. doi: 10.1172/JCI164317.
    PubMed         Abstract available
    
    

    
    J Infect Dis

34. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
    Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
    J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
    PubMed         Abstract available
    
    
35. ROBINSON JA, Niu M, Fox HS, Burdo TH, et al
    Antiretroviral therapy ameliorates SIV-associated myocarditis by dampening interferon signaling and pathogen response in the heart.
    J Infect Dis. 2023 Apr 19:jiad105. doi: 10.1093.
    PubMed         Abstract available
    
    
36. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.
    PubMed        
    
    
37. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed         Abstract available
    
    

    
    JAMA

38. HARRIS E
    World on Path to Eliminate AIDS as a Global Threat by 2030.
    JAMA. 2023;329:1248.
    PubMed        
    
    

    
    Lancet

39. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.
    PubMed        
    
    

    
    Nat Rev Immunol

40. BURTON DR
    Antiviral neutralizing antibodies: from in vitro to in vivo activity.
    Nat Rev Immunol. 2023 Apr 17:1-15. doi: 10.1038/s41577-023-00858.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

41. KWON PM, Lawrence S, Figueroa A, Robinson-Papp J, et al
    Autonomic Neuropathy as a Predictor of Morbidity and Mortality in People Living With HIV: A Retrospective, Longitudinal Cohort Study.
    Neurol Clin Pract. 2023;13:e200141.
    PubMed         Abstract available
    
    

    
    Pediatrics

42. LAMPE MA, Nesheim SR, Oladapo KL, Ewing AC, et al
    Achieving Elimination of Perinatal HIV in the United States.
    Pediatrics. 2023 Apr 18:e2022059604. doi: 10.1542/peds.2022-059604.
    PubMed         Abstract available
    
    
43. CHAKHTOURA N, Kapogiannis BG
    The Road to Zero Perinatal HIV Transmission in the United States.
    Pediatrics. 2023 Apr 18:e2022060209. doi: 10.1542/peds.2022-060209.
    PubMed        
    
    

    
    PLoS One

44. PEPPER K
    "If I don't take my treatment, I will die and who will take care of my child?": An investigation into an inclusive community-led approach to addressing the barriers to HIV treatment adherence by postpartum women living with HIV.
    PLoS One. 2023;18:e0271294.
    PubMed         Abstract available
    
    
45. BAASSI M, Moussaoui M, Soufi H, Rajkhowa S, et al
    Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations.
    PLoS One. 2023;18:e0284539.
    PubMed         Abstract available
    
    
46. MOYO I, Mavhandu-Mudzusi AH, Lipeleke F, Sibindi M, et al
    Access to HIV prevention, treatment, and care services during COVID-19 by men who have sex with men in Zimbabwe, An interpretive phenomenological analysis study.
    PLoS One. 2023;18:e0281799.
    PubMed         Abstract available
    
    
47. AUSTIN-KEILLER A, Park M, Yang S, Mayo NE, et al
    "Alone, there is nobody": A qualitative study of the lived experience of loneliness in older men living with HIV.
    PLoS One. 2023;18:e0277399.
    PubMed         Abstract available
    
    
48. AWAN A, Shakik S, Banack HR, Fisman DN, et al
    Hepatitis B and C in individuals with a history of antipsychotic medication use: A population-based evaluation.
    PLoS One. 2023;18:e0284323.
    PubMed         Abstract available
    
    

    
    Virology

49. ACCHIONI C, Acchioni M, Mancini F, Amendola A, et al
    A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation.
    Virology. 2023;583:1-13.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: